[
  {
    "info": {
      "NCT": "NCT05374512",
      "Protocol_No": "AstraZeneca_D926PC00001 TROPION_Breast02",
      "jit": "Avera Trials",
      "trial_name": "TROPION_Breast02"
    },
    "disease": {
      "summary": "Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer",
      "details": [
        {
          "code": "Adenoid Cystic Breast Cancer (ACBC)",
          "selection": "include",
          "stage": "Recurrent;Metastatic"
        },
        {
          "code": "Adenomyoepithelioma of the Breast (BRAME)",
          "selection": "include",
          "stage": "Recurrent;Metastatic"
        },
        {
          "code": "Breast Lobular Carcinoma In Situ (LCIS)",
          "selection": "include",
          "stage": "Recurrent;Metastatic"
        },
        {
          "code": "Breast Neoplasm, NOS (BNNOS)",
          "selection": "include",
          "stage": "Recurrent;Metastatic"
        },
        {
          "code": "Metaplastic Breast Cancer (MBC)",
          "selection": "include",
          "stage": "Recurrent;Metastatic"
        }
      ]
    },
    "query": {
      "nct": "NCT05374512",
      "title": "A Study of Dato-DXd Versus Investigator's Choice Chemotherapy in Patients With Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer, Who Are Not Candidates for PD-1/PD-L1 Inhibitor Therapy (TROPION-Breast02)",
      "current_status": "Recruiting",
      "status_verif_date": "April 2023",
      "last_update_date": "April 24, 2023",
      "trial_hold_status": "open",
      "sponsor": "AstraZeneca",
      "brief_summary": "This is a Phase III, randomised, open-label, 2 arm, multicentre, international study assessing the efficacy and safety of Dato-DXd compared with ICC in participants with locally recurrent inoperable or metastatic TNBC who are not candidates for PD-1/PD-L1 inhibitor therapy.",
      "conditions": "Breast Cancer",
      "type": "Interventional",
      "phase": "Phase 3",
      "arm": [
        {
          "ArmID": "1",
          "cohortlabel": "Dato-DXd",
          "drug": "Dato-DXd | NA | NA | NA | NA",
          "arm_type": "Experimental",
          "line_of_therapy": "3",
          "arm_hold_status": "open",
          "biomarker": [
            {
              "cohort": "Dato-DXd",
              "Gene": "Not available",
              "Gene2": "Not available",
              "Type": "ER (IHC/FISH)",
              "Variant": "Not available",
              "Selection": "include",
              "Function": "Negative",
              "summary": "ER IHC Negative"
            },
	    {
              "cohort": "Dato-DXd",
              "Gene": "Not available",
              "Gene2": "Not available",
              "Type": "PR (IHC/FISH)",
              "Variant": "Not available",
              "Selection": "include",
              "Function": "Negative",
              "summary": "PR IHC Negative"
            },
	    {
              "cohort": "Dato-DXd",
              "Gene": "Not available",
              "Gene2": "Not available",
              "Type": "HER2 (IHC/FISH)",
              "Variant": "Not available",
              "Selection": "include",
              "Function": "Negative",
              "summary": "HER2 IHC Negative"
            },
	    {
              "cohort": "Dato-DXd",
              "Gene": "Not available",
              "Gene2": "Not available",
              "Type": "PD-L1",
              "Variant": "Not available",
              "Selection": "include",
              "Function": "Negative",
              "summary": "PD-L1 Negative"
            },
	    {
              "cohort": "Dato-DXd",
              "Gene": "Not available",
              "Gene2": "Not available",
              "Type": "PD-L1",
              "Variant": "Not available",
              "Selection": "include",
              "Function": "Positive",
              "summary": "PD-L1 Positive"
            }
          ]
        },
        {
          "ArmID": "2",
          "cohortlabel": "Investigator's Choice of Chemotherapy (ICC)",
          "drug": "Paclitaxel | Nab-paclitaxel | Carboplatin | Capecitabine | Eribulin mesylate",
          "arm_type": "Active Comparator",
          "biomarker": [
            { 
	      "cohort": "Investigator's Choice of Chemotherapy (ICC)",
              "Gene": "Not available",
              "Gene2": "Not available",
              "Type": "PD-L1",
              "Variant": "Not available",
              "Selection": "include",
              "Function": "Positive",
              "summary": "PD-L1 Positive"
	    },
            {
              "cohort": "Investigator's Choice of Chemotherapy (ICC)",
              "Gene": "Not available",
              "Gene2": "Not available",
              "Type": "ER (IHC/FISH)",
              "Variant": "Not available",
              "Selection": "include",
              "Function": "Negative",
              "summary": "ER IHC Negative"
            },
            {
              "cohort": "Investigator's Choice of Chemotherapy (ICC)",
              "Gene": "Not available",
              "Gene2": "Not available",
              "Type": "PR (IHC/FISH)",
              "Variant": "Not available",
              "Selection": "include",
              "Function": "Negative",
              "summary": "PR IHC Negative"
            },
            {
              "cohort": "Investigator's Choice of Chemotherapy (ICC)",
              "Gene": "Not available",
              "Gene2": "Not available",
              "Type": "HER2 (IHC/FISH)",
              "Variant": "Not available",
              "Selection": "include",
              "Function": "Negative",
              "summary": "HER2 IHC Negative"
            },
	    {
              "cohort": "Investigator's Choice of Chemotherapy (ICC)",
              "Gene": "Not available",
              "Gene2": "Not available",
              "Type": "PD-L1",
              "Variant": "Not available",
              "Selection": "include",
              "Function": "Negative",
              "summary": "PD-L1 Negative"
            }
          ]
        }
      ],
      "docs": "<a href=\"https://avera-ereg-prod.forteresearchapps.com/ereg-web/protocols/2622/section-6057\" target=\"_blank\">eREG<\/a>",
      "doclastupdate": "2023-05-11",
      "locations": "Sioux Falls SD",
      "min_age": "18 Years",
      "gender": "All",
      "link": "<a href=\"https://clinicaltrials.gov/ct2/show/NCT05374512\" target=\"_blank\">NCT05374512<\/a>"
    }
  }
]
